• Return to Headlines

42.2% Return Seen to Date on SmarTrend Keryx Biopharm Call (KERX)

By Shiri Gupta

SmarTrend identified an Uptrend for Keryx Biopharm (NASDAQ:KERX) on October 4th, 2016 at $5.48. In approximately 10 months, Keryx Biopharm has returned 42.15% as of today's recent price of $7.79.

In the past 52 weeks, Keryx Biopharm share prices have been bracketed by a low of $4.03 and a high of $8.38 and are now at $7.79, 93% above that low price. Over the past week, the 200-day moving average (MA) has gone down 1.7% while the 50-day MA has advanced 3.4%.

Keryx Biopharmaceuticals, Inc. is focused on developing and commercializing pharmaceuticals for the treatment of renal disease. The Company's product candidate completed Phase 3 testing, pursuant to an SPA agreement with the FDA, for hyperphosphatemia in ESRD patients. The product candidate is also in Phase 2 for non-dialysis dependent CKD patients with iron-deficiency anemia.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Keryx Biopharm shares.

Log in and add Keryx Biopharm (KERX) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights keryx biopharm

Ticker(s): KERX